Are memory issues typical for patients with myelofibrosis? Is aspirin the answer? In this Ask the Expert segment, Dr. Prithviraj…
Dr. Sima Porten, MD MPH, Assistant Professor, Department of Urology UCSF answers the question What are some of the limitations…
Dr. Sima Porten, MD MPH, Assistant Professor, Department of Urology UCSF answers the question What patients should be selected for…
Kamran Ahrar, MD, MBA, Professor, Interventional Radiology answers the question Why is renal tumor ablation underutilized?
Kamran Ahrar, MD, MBA, Professor, Interventional Radiology answers the question what is the current role of renal tumor ablation?
hillip M. Pierorazio, MD, Assistant Professor of Urology and Oncology, Brady Urological Institute, Sidney Kimmel Cancer Center, Johns Hopkins Hospital…
Phillip Pierorazio, MD, Assistant Professor of Urology and Oncology, Brady Urological Institute, Sidney Kimmel Cancer Center, Johns Hopkins Hospital outlines…
Dr. Daniel Heng MD @DrDanielHeng University of Calgary discusses genomic investigation in the ASSURE and S-TRAC adjuvant trials.
Daniel Heng, MD University of Calgary @DrDanielHeng describes what is the role of genomic investigation in predicting recurrence of local…
Alexander Kutikov, MD, FACS, Associate Professor of Urologic Oncology Fox Chase Cancer Center answers the question of what is the…
Alexander Kutikov, MD, FACS explains the current standards of care for renal mass biopsies at the 2016 annual International Kidney…
Aly-Khan A. Lalani, MD of the University of Alberta gives a quick overview of the latest in Proton Pump Inhibitors…
Paula Ragan, CEO of X4 Pharmaceuticals gives a quick overview of her presentation at the 2016 annual International Kidney Cancer…
Professor Thomas Powles MBBS, MRCP, MD, Barts Cancer Institute presents Clinical outcomes based on MET expression level in METEOR, a…
Toni K. Choueiri, MD, Director and Disease Center Leader, The Lank Center for Genitourinary Oncology, President of Medical Staff, Dana-Farber…
Brian I. Rini, M.D., Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Center presents Axitinib is an Ideal Choice…
Thomas E Hutson, DO, PharmD FACP Director, GU Oncology Program, Co-Director, Urologic Cancer Research and Treatment Center, Texas Oncology/ Baylor…
Nizar M. Tannir, MD, FACP, Professor and Deputy Chair, GU Medical Oncology, MD Anderson presents Cabozantinib is the best salvage…
Saby George, MD, FACP, Associate Professor of Medicine and Oncology, Genitourinary Oncology Program , Roswell Park Cancer Institute presents Nivolumab…
HIF-2 Inhibitor discussion at the 2016 annual International Kidney Cancer Symposium.
… 77 year WF presents with back painHistory of renal cell carcinoma, s/p right radical nephrectomy in 2000T1bN0M0 Clear cell…
Bernard Escudier, Institut Gustave Roussy presents Developing the next generation of studies in RCC at the 2016 annual International Kidney…
James Brugarolas, M.D., Ph.D., Kidney Cancer Program Leader, Virginia Murchison Linthicum Endowed Scholar, Associate Professor of Internal Medicine University of…
Axel Bex, MD, PhD, The Netherlands Cancer Institute presents Durable Responses: How Do We Get There? The role of metastasectomy…
Dylan Martini, MD, Dana-Farber Cancer Institute presents Outcomes in PD-1/PD-L1 inh. responders who discontinued therapy for immune-related adverse events: Analysis…
James J. Hsieh, MD, PhD, Memorial Sloan Kettering Cancer Center presents Differential Overall Survival Results in RECORD-3 Study Based on…
Lana Hamieh, MD, Research Fellow in Medicine (EXT) presents Characterization of Patients with Poor-Risk Metastatic Renal Cell Carcinoma at the…
Jun Gong, Fellow, City of Hope presents Latency of potential treatment-related adverse events among patients treated with TKI/VEGF-directed therapy for…
Jill Rachel Mains, MD, Dept. of Radiology and Oncology, Aarhus University Hospital presents Baseline Low B-value Diffusion-weighted Magnetic Resonance Imaging…
Rana McKay, MD, Dana-Farber, presents Impact of Aspirin and Non-Aspirin NSAIDs on Outcomes in Metastatic RCC at the 2016 annual…
Aly-Khan A. Lalani, Department of Medical Oncology, Cross Cancer Institute, University of Alberta presents Proton Pump Inhibitors and Survival Outcomes…
Chung-Han Lee, MD, PhD, Medical Oncologist, Memorial Sloan Kettering presents Medullary Renal Cell Carcinoma (RCC): Genomics and Treatment Outcomes at…
Maria Becerra, Research Fellow at Memorial Sloan Kettering Cancer Center presents Characterization of genomic alterations associated with metastatic tropism in…
Thomas Hutson, Memorial Sloan Kettering Cancer Center, New York, NY presents A randomized phase 2 trial of CRLX101 in combination…
Rana McKay, MD, Assistant Professor of Medicine, HMS/DFCI/BWH presents PD-1/PD-L1 Blockage in Non-Clear Cell RCC at the 2016 annual International…
Toni K. Choueiri Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute presents Savolitinib (volitinib, AZD6094, HMPL-504): Future Directions at the…
Primo N. Lara, Jr., MD, Professor of Medicine, University of California Davis School of Medicine, Acting Director, UC Davis Comprehensive…
Laurence Albiges, MD, Gustave Roussy presents Crizotinib In Papillary RCC at the 2016 annual International Kidney Cancer Symposium.
Brian Shuch, MD, Assistant Professor of Urology/Radiology, Yale School of Medicine presents Developments in Biology of Non-Clear Cell RCC at…
Debate: Kidney Cancer: Should we explore drug combination strategies in an adjuvant setting?
Priti S. Hegde, PhD, Director, CI Franchise Lead, Biomarkers Genentech Roche presents Blocking VEGF in addition to checkpoint inhibition in…
Paula Ragan, CEO, X4 Pharmaceuticals presents Addressing Unmet Need in ccRCC Through Targeted CXCR4 Blockade at the 2016 annual International…
Christopher Turner, MD, Vice President, Clinical Science presents Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates at the 2016 annual…
Ian M. Waxman, MD, Bristol-Myers Squibb presents New opportunities for immuno-oncology in renal cell carcinoma at the 2016 annual International…
Moderator Michael B. Atkins , Georgetown-Lombardi Comprehensive Cancer Center participates in a debate: In 2020 Which Approach do you predict…
Neeraj Agarwal, MD, Associate Professor of Medicine Director, GU Medical Oncology, Huntsman Cancer Institute presents Toxicities with PD-1 Inhibitors: The…
Tian Zhang, MD, Duke Cancer Institute, Duke University Medical Center presents “Vaccines in Renal Cell Carcinoma: A Lost Cause or…
Guru Sonpavde, MD, Associate Professor of Medicine Director, Urologic Oncology, UAB Comprehensive Cancer Center presents Sequencing VEGF and PD-1 Inhibition…
Hans Hammers MD, PhD, Kidney Cancer Program, UT Southwestern presents PD1 and CTLA4 Inhibition in RCC at the 2016 annual…
David McDermott, MD, Leader, Kidney Cancer Program Dana-Farber/Harvard Cancer Center presents To Combine: VEGF + PD-1 at the 2016 annual…
Charles G. Drake MD / PhD, Director GU Medical Oncology, Co-Director Immunotherapy Program, Associate Director for Clinical Research, Herbert Irving…
Robert G. Uzzo, M.D.Willing G. Pepper Chairman of Surgery Fox Chase Cancer Center, Temple University School of Medicine Chair, Department…
Mohamad E. Allaf, MD, Associate Professor of Urology, Oncology, & BME MEA Endowed Director, Minimally Invasive Surgery Johns Hopkins Medicine…
Sumanta K. Pal, MD, City of Hope Comprehensive Cancer Center presents Atezolizumab Adjuvant Study: Medical Oncologist Perspective at the 2016…
Lauren C. Harshman MD, Assistant Professor of Medicine, Harvard Medical School, Dana-Farber, presents a strong case for a neoadjuvant/adjvuant approach…
Naomi B. Haas, MD, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University…
Bradley C. Leibovich, MD, FACS, Chair, Department of Urology, David C. Utz Professor of Urology, Mayo Clinic, Rochester, MN presents…
Jose A. Karam, MD, FACS, Assistant Professor, Department of Urology, MD Anderson asks “Cytoreductive Nephrectomy: Yes, No, Clinical Trial?” at…
R. Houston Thompson, MD, Professor of Urology, Mayo Clinic presents Cytoreductive Nephrectomy: Optimizing Surgical Outcomes and Minimizing Complications at the…
E. Jason Abel, MD, FACS, Associate Professor, Department of Urology, University of Wisconsin presents Cytoreductive nephrectomy in locally advanced renal…
Viraj Master MD PhD FACS, Professor Associate Chair for Clinical Affairs and Quality, Director of Clinical Research Unit Department of…
Ithaar H. Derweesh, M.D., University of California, San Diego asks the question “Neoadjuvant Therapy: Where are we in 2016?” at…
Kamran Ahrar, MD, MBA, Professor, Interventional Radiology presents Renal Tumor Ablation: Current Technologies and Outcomes at the 2016 annual International…
Phillip M. Pierorazio, MD, Assistant Professor of Urology and Oncology, Brady Urological Institute, Sidney Kimmel Cancer Center, Johns Hopkins Hospital,…
Alexander Kutikov, MD, FACS, Associate Professor of Urologic Oncology Fox Chase Cancer Center, Philadelphia, PA presents “Renal Biopsy: Always, Sometimes…
Brandon Manley presents Characterizing Recurrent And Lethal Small Renal Masses In Clear Cell Renal Cell Carcinoma Using Recurrent Somatic Mutations…
Dr. Nicholas G. Cost, M.D. Assistant Professor, Department of Surgery, Division of Urology University of Colorado Cancer Center presents RCC…
Dr. Karim Touijer, MD, MPH. Memorial Sloan-Kettering Cancer Center presents Surgery for cT1b RCC: Partial Nephrectomy, Radical nephrectomy, Clinical Trial?…
Dr. Daniel Heng MD MPH FRCPC of Tom Baker Cancer Center, University of Calgary @DrDanielHeng presents Renal cell carcinoma prognostication…
Dr. Sima Porten, MD MPH, Assistant Professor, Department of Urology UCSF presents Partial Nephrectomy 2016, Techniques, Outcomes, and Selection at…
Dr. Jamil Syed BS Research Fellow of Yale Department of Urology presents The Incidence and Predictive Factors of Metachronous Bilateral…
Is stem cell transplant (SCT) a viable option for MPN patients? Noted MPN specialist and researcher, Dr. David Snyder from…
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany, talks about individualized treatment and delivering the right treatment for the…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, discusses how sharing data between groups on cancer can help…
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about how to overcome mental health issues that…
Jennifer Woyach, MD of The Ohio State University Comprehensive Cancer Center, Columbus, OH talks developments in chronic lymphocytic leukaemia (CLL)…
Jasmin Bahlo, PhD of University of Cologne, Cologne, Germany talks about the analysis of the projects that are underway at…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, discusses how best to deal with Richters transformation. Dr Eichhorst…
Federico Caligris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about new treatment and traditional treatment options for chronic…
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about how he thinks clinicians should talk to…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, discusses potential concerns with venetoclax. The advantage of venetoclax is…
Carsten Niemann, MD, PhD of Rigshospitalet, Copenhagen, Denmark, provides brief guidance on preventing infections in chronic lymphocytic leukemia (CLL) patients.…
Jennifer Woyach, MD of The Ohio State University Comprehensive Cancer Center, Columbus, OH talks about selinexor for chronic lymphocytic leukaemia…
Nicholas Chiorazzi, MD from The Feinstein Institute for Medical Research, Manhasset, NY discusses how cell surface markers change over time…
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany, discusses the cost of treatment and collaborations in chronic lymphocytic leukemia…
Carsten Niemann, MD, PhD of Rigshospitalet, Copenhagen, Denmark, provides an overview of what we are learning about chronic lymphocytic leukemia…
Federico Caligaris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about the collaboration of the solid tumor and liquid…
Michael Hallek, MD, PhD of the University of Cologne, Cologne, Germany talks about new International Workshop on Chronic Lymphocytic Leukemia…
Jasmin Bahlo, PhD of University of Cologne, Cologne, Germany gives an overview CLL-IPI and its use in chronic lymphocytic leukemia…
Michael Keating, MD, BS of MD Anderson Cancer Center, Houston, TX discusses challenges in chronic lymphocytic leukemia (CLL) at the…
Michael Hallek, MD, PhD of the University of Cologne, Cologne, Germany discusses new chronic lymphocytic leukemia (CLL) treatments and FCR…
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany, provides an overview of the 2016 International Workshop of the German…
Jasmin Bahlo, PhD of University of Cologne, Cologne, Germany gives an overview of her talk on CLL-IPI held at the…
Michael Brown, MBBS, FRACP, FRCPA from the Royal Adelaide Hospital, Adelaide, Australia discusses the history of cancer immunotherapy. Historically speaking,…
Lisa Beatty, PhD, of Flinders University, Adelaide, Australia discusses optimism towards online interventions for supportive care. There is now a…
Charles Loprinzi, MD of Mayo Clinic, Rochester, MN discusses neuropathy treatment options. ASCO guidelines recommend duloxetine, an antidepressant medication, which…
Nicole Kiss, PhD, Adv APD of Peter MacCallum Cancer Centre, Melbourne, Australia discusses the significance of nutrition to lung cancer…
Lisa Beatty, PhD, of Flinders University, Adelaide, Australia, discusses online interventions as a new, innovative approach to supportive care treatment.…
Jervoise Andreyev, MA, PhD, FRCP of The Royal Marsden NHS Foundation Trust, London, United Kingdom gives an overview of Helsinn-sponsored…
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about current research to overcome T-cell dysfunction in…
Federico Caligris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about how he thinks doctors should interact with their…
Carlo Croce, MD of The Ohio State University, Columbus, OH discusses drug combination for chronic lymphocytic leukemia (CLL) at the…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, provides a brief overview of previous and current trial results…
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about the combination of chronic lymphocytic leukemia (CLL)…
I recently changed from crizotinib (Xalkori) to alectinib (Alecensa). Should I assume new therapies will bring on new side effects?…
John Byrd, M.D., The Ohio State University Comprehensive Cancer Center, discusses how LLSs Beat AML Master Trial aligns with the…
Ross Levine, M.D., Memorial Sloan Kettering Cancer Center describes The Leukemia & Lymphoma Societys Beat AML Master Trial.
Brian Druker, M.D., OHSU Knight Cancer Institute, discusses how the Beat AML initiative addresses the urgent need for a new…
Louis DeGennaro, Ph.D., President and CEO of The Leukemia & Lymphoma Society (LLS) explains LLSs leadership role in going on…
Bettina Ryll, MD, PhD of Melanoma Patient Network Europe talks about the role of drug development and clinical trials for…
Matthew Ellis, MB, BChir, PhD, FRCP of Baylor College of Medicine, Houston, TX discusses take-home messages from the Phase III…
Bettina Ryll, MD, PhD of Melanoma Patient Network Europe gives an overview of the sessions by the Melanoma Patient Network…
Martin Reck, MD, PhD of LungenClinic Grosshansdorf, Grosshansdorf, Germany discusses the implication of the KETNOTE-024 trial results for advanced lung…
Mansoor Mirza, MD of Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark gives an overview of the results of the ENGOT-OV16/NOVA Phase…
Alessandro Gronchi, MD of the National Cancer Institute, Milan, Italy gives a press brief about the results of an interim…
Toni Choueiri, MD of Dana-Farber Cancer Institute, Boston, MA gives a press brief about the results of the CABOSUN trial…
Alexander Eggermont, MD, PhD, of the Gustave Roussy Institute, Villejuif, France, gives a press brief about the EORTC 18071 randomized…
Gabriel Hortobagyi, MD, FACP, of the The University of Texas MD Anderson Cancer Center, Houston, TX, gives a summary of…
Jonathan Ledermann, MD, FRCP from University College Hospital, London, UK discusses the advancement of poly ADP ribose polymerase (PARP) inhibitor…
Toni Choueiri, MD of the Dana-Farber Cancer Institute, Boston, MA gives an overivew of the CABOSUN trial of cabozantinib compared…
Martin Reck, MD, PhD of LungenClinic Grosshansdorf, Grosshansdorf, Germany gives an overview of the KEYNOTE-024 trial results for non-small cell…
Mansoor Mirza, MD of Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark gives an overview of the ENGOT-OV16/NOVA Phase III trial of…
Jonathan Ledermann, MD, FRCP from University College Hospital, London, UK speaks to us about the development of poly ADP ribose…
Ursula Matulonis, MD of the Dana-Farber Cancer Institute, Boston, MA talks about the ENGOT-OV16/NOVA trial, a trial of women with…
Sven Mahner, MD, PhD of the University Medical Center Hamburg-Eppendorf Hamburg, Germany talks about next steps for the ENGOT-OV16/NOVA Phase…
Toni Choueiri, MD of the Dana-Farber Cancer Institute, Boston, MA provides an overview of his talk on biomarkers of response…
In this press brief Q&A from ESMO 2016, Solange Peters, MD, PhD of Lausanne University Hospital, Lausanne, Switzerland, Lidija Kandolf-Sekulovic,…
Fortunato Ciardiello, MD, PhD of Second University of Naples, Naples, Italy gives a press brief about the key messages of…
Josep Tabernero, MD, PhD of Vall d’Hebron University Hospital, Barcelona, Spain follows on from the press brief by Prof. Lidija…
Lidija Kandolf-Sekulovic, MD, PhD of the Military Medical Academy, Belgrade, Serbia gives a press brief on the results of the…
Andrés Cervantes, MD, PhD of University of Valencia, Valencia, Spain introduces the press conference and the presidential symposia at ESMO…
Ulrik Lassen, MD, PhD of Copenhagen University Hospital, Copenhagen, Denmark talks about cancer in Denmark and the role of ESMO…
Solange Peters, MD, PhD of Lausanne University Hospital, Lausanne, Switzerland kicks-off the first press conference at ESMO 2016. This year’s…
Federico Caligris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about the key questions to be discussed at International…
Federico Caligris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about the International Workshop on Chronic Lymphocytic Leukemia (iwCLL),…
Carlo Croce, MD of The Ohio State University, Columbus, OH provides an overview of microRNA and ROR1 as part of…
“Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany talks about the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), which…
Nicholas Chiorazzi, MD from The Feinstein Institute for Medical Research, Manhasset, NY provides an overview of the program of the…
Federico Caligaris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, disucsses how to removal of macrophages can stop progression of…
Carsten Niemann, MD, PhD of Rigshospitalet, Copenhagen, Denmark dicusses the development of new advanced methods to identify chronic lymphocytic leukemia…
Carlo Croce, MD of The Ohio State University, Columbus, OH provides an overview of his research on the epigenetics and…
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about the problem of resistance to new drugs…
How the Cleveland Clinic uses Tomosynthesis Mammogram with Dr. Leah Sieck, MD Diagnostic Radiologist
Dr. Chirag Shah, MD Radiation Oncologist at Cleveland Clinic discusses several new radiation methods he uses for breast cancer patients.
Dr. Charis Eng, MD Chair and Founding Director of Cleveland Clinic Genomic Medicine Institute outlines the guidelines that the Cleveland…
Leah Sieck, MD Diagnostic Radiologist and Jame Abraham, MD of Cleveland Clinic discuss the guidelines that they use in breast…
Topics: How do you get all team members to work together? How does this collaboration improve patient care and value…
In this Ask the Expert segment, Dr. Larry Anderson, Jr. of University of Texas Southwest Medical Center answers a question…
Clemens Schmitt, MD of the Max Delbruck Center for Molecular Medicine, Berlin, Germany discusses the clinical implications of targed therapies…
“Laurie Sehn, MD of British Columbia Cancer Agency, Vancouver, Canada discusses the standard of care for patients with diffuse large…
“Clemens Schmitt, MD of the Max Delbruck Center for Molecular Medicine, Berlin, Germany discusses the ongoing debate about the two…
Andrew Davies, MRCP, PhD of University Hospital of Southampton, Southampton, UK talks about upcoming trials in diffuse large B-cell lymphoma…
“Laurie Sehn, MD of British Columbia Cancer Agency, Vancouver, Canada discusses the use of PET scan to identify diffuse large…
Clemens Schmitt, MD of the Max Delbruck Center for Molecular Medicine, Berlin, Germany discusses the potential to use targeted therapy…
“Bjoern Chapuy, MD, PhD of Dana-Farber Cancer Institute, Boston, MA gives an overview of his talk on targeted molecular signatures…
Andrew Davies, MRCP, PhD of University Hospital of Southampton, Southampton, UK discusses his highlights from the 2016 International Workshop on…
Jeffrey Weber, MD, PhD from the NYU Langone Medical Center, New York, NY discusses his talk on novel combination therapies…
Larisa Geskin, MD of Columbia University Medical Center, New York, NY summarizes her views on the developments and upcoming meetings…
Victoria Sherwood , PhD of the University of Dundee, Dundee, UK, talks about the next steps for the research into…
Robert Andtbacka, MD, CM of the Huntsman Cancer Institute, Salt Lake City, UT talks about neoadjuvant studies at the 2016…
“Peter Petzelbauer, MD, of the Medical University of Vienna, Vienna, Austria, discusses the differences in number of clinical trials for…
Robert Knobler, MD of the Medical University of Vienna, Vienna, Austria talks about the future of extracorporeal photopheresis for the…
Robert Andtbacka, MD, CM of the Huntsman Cancer Institute, Salt Lake City, UT discusses the use of oncolytic viruses at…
Jürgen Becker, MD, PhD from the University Hospital Essen, Essen, Germany speaks to us on the importance of stratified treatments…
Jeffrey Weber, MD, PhD from the NYU Langone Medical Center, New York, NY discusses what he hopes to achieve with…
Maria Concetta Fargnoli, MD, form the University of LAquila, LAquila, Italy discusses the developments made in melanoma genetics owing to…
“Peter Petzelbauer, MD, of the Medical University of Vienna, Vienna, Austria, discusses the next steps for his research and clinical…
Paul Lorigan, MB, BCH, BAO, BA, FRCP of the University of Manchester, Manchester, UK, discusses the problem of chemotherapy for…
“Peter Petzelbauer, MD, of the Medical University of Vienna, Vienna, Austria, discusses the role of lymphangiogenesis in melanoma at the…
Paolo Ascierto, MD of the National Tumor Institute Fondazione G. Pascale, Naples, Italy discusses drug combinations in melanoma as part…
Maria Concetta Fargnoli, MD, form the University of LAquila, LAquila, Italy discusses genetic screening in melanoma at the 2016 World…
Martin Mihm, Jr., MD of Brigham and Women’s Hospital, Boston, MA, discusses the importance of therapeutic checkpoint blockers at the…
Larisa Geskin, MD of Columbia University Medical Center, New York, NY discusses the future of the treatment of cutaneous T-cell…
Jürgen Becker, MD, PhD from the University Hospital Essen, Essen, Germany discusses new innovative treatment options for Merkel cell carcinoma…
Jeffrey Weber, MD, PhD of the NYU Langone Medical Center, New York, NY discusses combination therapy options for melanoma at…
Isaac Brownell, MD, PhD of the National Cancer Institute, Bethesda, MD discusses the virus associated with Merkel cell carcinoma and…
Brigitte Dréno, MD, PhD from the University Hospital of Nantes, Nantes, France discusses current and future clinical trials in melanoma…
Marc Peeters, MD, PhD, of Antwerp University Hospital, Edegem, Belgium, gives a summary of some of the data presented on…
Dr Mansoor Mirza, chief oncologist at Copenhagen University Hospital, Denmark and medical director of the Nordic Society of Gynaecological Oncology…
Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, provides an insight into BRAF and…
Brigitte Dréno, MD, PhD from the University Hospital of Nantes, Nantes, France discusses vaccination and T-cell adoptive therapies for the…
Victoria Sherwood , PhD of the University of Dundee, Dundee, UK, talks about Wnt signalling at the 2016 World Congress…
Stephan Grabbe, MD of the University Medical Center, Johannnes Gutenberg University Mainz, Mainz, Germany discuses cutaneous immunology at the 2016…
Robert Knobler, MD of the Medical University of Vienna, Vienna, Austria talks about extracorporeal photopheresis in the treatment of cutaneous…
Robert Andtbacka, MD, CM of the Huntsman Cancer Institute, Salt Lake City, UT talks about the update on the randomized…
Paul Lorigan, MB, BCH, BAO, BA, FRCP of the University of Manchester, Manchester, UK, discusses key points from his talk…
Paolo Ascierto, MD of the National Tumor Institute Fondazione G. Pascale, Naples, Italy discusses biomarkers in melanoma as part of…
Larisa Geskin, MD of Columbia University Medical Center, New York, NY gives an overview of her talk on chemotherapy for…
Jürgen Becker, MD, PhD from the University Hospital Essen, Essen, Germany discusses the symposium on Merkel cell carcinoma treatment at…
Martin Mihm, Jr., MD of Brigham and Women’s Hospital, Boston, MA gives an overview of the session on open quesions…
Jean-Jacques Grob, MD of Aix Marseille University and APHM Hospital CHU Timone, Marseille, France discusses the idea of focussing on…
Isaac Brownell, MD, PhD of the National Cancer Institute, Bethesda, MD provides insight into the possible mechanisms of Merkel cell…
Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, suggests next steps for poor prognosis…
Giovanni Pellacani, MD of the University of Modena and Reggio Emilia, Modena, Italy, explores the importance of building up a…
In this presentation from the JAK Inhibitors in Myeloproliferative Neoplasms symposium, held August 27, 2016 in Alexandria, VA, Dr. Ruben…
In this presentation from the JAK Inhibitors in Myeloproliferative Neoplasms symposium, held August 27, 2016 in Alexandria, VA, Dr. Srdan…
In this presentation from the JAK Inhibitors in Myeloproliferative Neoplasms symposium, held August 27, 2016 in Alexandria, VA, Dr. Stephen…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Luca Malcovti discusses the genetic…
Watch as this breast cancer patient talks about on the side effects while on anti-estrogen therapy. She also gives advice…
Extend or End Endocrine Therapy After Year 5 for ER+ Breast Cancer Patients? Please visit http://www.breastcancerindex.com for more information. Facebook:…
This breast cancer patient talks about her negative side effects while on anti-estrogen therapy. She also shares how she learned…
This breast cancer patient gives her advice on the negative side effects while on anti-estrogen therapy. She also shares how…
What is Breast Cancer Index you may ask? Breast Cancer Index(SM) is a test that can help you and your…
What resources are available for cancer patients? When you are diagnosed with cancer, you feel like youve lost control of…
Michael Hallek, MD, PhD of the University of Cologne, Cologne, Germany discusses the iwCLL 2017 meeting to be held in…
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany discusses the upcoming CLL2-GIVe trial on chronic lymphocytic leukemia (CLL) at…
Nicholas Chiorazzi, MD from The Feinstein Institute for Medical Research, Manhasset, NY discusses his research on the life cycle of…
Michael Hallek, MD, PhD of the University of Cologne, Cologne, Germany discusses highlights from the 2016 International Workshop of the…
John Gribben, MD, DSc, FRCPath, FMed Sci of Barts Cancer Institute, London, UK discusses the place of allogeneic stem cell…
Dan Landau, MD, PhD of Weill Cornell Medical College and the NYGC, New York, NY gives an overview of his…
Carsten Niemann, MD, PhD of Rigshospitalet, Copenhagen, Denmark gives an overview of his talk on the treamtent of previously treated…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany gives an overview of the GCLLSG trials in chronic lymphocytic…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany gives an overview of her talk on therapy for previously…
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands gives an overview of his talk on resistance to…
Christian Chabannon, MD, PhD of Institut Paoli Calmettes, Marseilles, France and President of the EBMT 2017 Annual Meeting talks about…
Mohamad Mohty, MD, PhD of Saint-Antoine Hospital, Paris, France and EBMT President gives an overview of the program of the…
Jan Styczynski, MD, PhD of Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland and provides an overview of the Infectious Diseases…
Christian Chabannon, MD, PhD of Institut Paoli Calmettes, Marseilles, France and President of the EBMT 2017 Annual Meeting discusses the…
Mohamad Mohty, MD, PhD of Saint-Antoine Hospital, Paris, France and EBMT President provides an overview of the EBMT International Transplant…
Laurent Garderet, MD of Saint-Antoine Hospital, Paris, France gives an overview of his talk autologous hematopoietic stem cell transplantation (HSCT)…
Jan Styczynski, MD, PhD of Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland and Chair of the EBMT Infectious Diseases Working…
Christian Chabannon, MD, PhD of Institut Paoli Calmettes, Marseilles, France and President of the EBMT 2017 Annual Meeting provides an…
Anna Sureda, MD, PhD of Duran I Reynals Hospital, Barcelona, Spain gives an overview of her talk on how new…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
In this presentation from the 2016 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, held August 26-27 in Alexandria, VA,…
Filmed on location in Alexandria, Virginia on August 27, 2016, this Expert Perspectives discussion features a panel of experts summarizing…
This activity is an online webinar featuring the conference co-chairs, who highlight the key points presented during the US Focus…
Brigitte Dréno, MD, PhD of the University Hospital of Nantes, Nantes, France discusses vaccinations for melanoma and the decrease in…
Beate Lichtenberger, PhD of the Medical University of Vienna, Vienna, Austria, provides an insight into the new research that is…
Jeffrey Weber, MD, PhD of the NYU Langone Medical Center, New York, NY, discusses his satellite symposium talk on updates…
Jean-Jacques Grob, MD of the Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France, discusses treatments for melanoma patients with…
Isaac Brownell, MD, PhD of the National Cancer Institute, Bethesda, MD discusses current studies into Merkel cell carcinoma while attending…
Ichiro Okamoto, MD of the Medical University of Vienna, Vienna, Austria discusses the importance of genetic testing for skin cancer.…
Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the two currently approved combination…
Giovanni Pellacani, MD of the University of Modena and Reggio Emilia, Modena, Italy, discusses the challenges surrounding the idea of…
Gerold Schuler, MD of University Hospital Erlangen, Erlangen, Germany discusses the importance of collaboration in cancer research at the 2016…
What is Lorem Ipsum? Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the…
Paolo Ascierto, MD of the National Tumor Institute Fondazione G. Pascale, Naples, Italy provides an overview of his talk on…
Martin Mihm, Jr., MD of Brigham and Women’s Hospital, Boston, MA gives an overview of his talk on open questions…